Centogene N V Quick Ratio (CNTG) starting from the fourth quarter 2023 to fourth quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Centogene N v   (NASDAQ: CNTG)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Centogene N V 's Quick Ratio

CNTG's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the fourth quarter 2023, Quick Ratio deteriorated to 0.44 a new company low.

Within Medical Laboratories industry 29 other companies have achieved higher Quick Ratio than Centogene N V in fourth quarter 2023. While Quick Ratio total ranking in the fourth quarter 2023 has deteriorated compared to the prior quarter from 2127 to 2602.

Explain Quick Ratio?
How much Cash & cash equivalents CNTG´s has?
What are CNTG´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CNTG Quick Ratio (Dec 31 2023)
Q4		 0
Q3		 0
Q2		 0
Q1		 (Dec 31 2022)
Q4
Y / Y Current Liabilities Change 8.28 % 8.28 % 8.28 % 8.28 % 1.41 %
Y / Y Cash & cash equivalent Change -46.87 % -46.87 % -46.87 % -46.87 % 101.77 %
Quick Ratio MRQ 0.44 0.44 0.44 0.44 0.9
CNTG's Total Ranking # 2602 # 2127 # 2127 # 2129 # 1880
Seq. Current Liabilities Change 0 % 0 % 0 % 8.28 % 0 %
Seq. Cash & cash equivalent Change 0 % 0 % 0 % -46.87 % 0 %



Quick Ratio fourth quarter 2023 Company Ranking
Within: No.
Medical Laboratories Industry # 30
Healthcare Sector # 773
Overall Market # 2602


Quick Ratio Statistics
High Average Low
0.9 0.6 0.44
(Dec 31 2022)   (Dec 31 2023)




Financial Statements
Centogene N V 's Current Liabilities $ 49 Millions Visit CNTG's Balance sheet
Centogene N V 's Cash & cash equivalent $ 21 Millions Visit CNTG's Balance sheet
Source of CNTG's Sales Visit CNTG's Sales by Geography


Cumulative Centogene N V 's Quick Ratio

CNTG's Quick Ratio for the trailling 12 Months

CNTG Quick Ratio

 (Dec 31 2023)
12 Months		 0
12 Months		 0
12 Months		 0
12 Months		 (Dec 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth 8.28 % 6.58 % 4.87 % 3.14 % 1.41 %
Y / Y Cash & cash equivalent TTM Growth -46.87 % -25.8 % 2.38 % 42 % 101.77 %
Quick Ratio TTM 0.44 0.55 0.66 0.78 0.9
Total Ranking TTM # 4643 # 3344 # 3331 # 3372 # 3363
Seq. Current Liabilities TTM Growth 1.95 % 1.99 % 2.03 % 2.07 % 0.35 %
Seq. Cash & cash equivalent TTM Growth -18.07 % -15.31 % -13.27 % -11.72 % 14.43 %

Quick ratio ranking by company, industry and sector >> Back to CNTG Financial Strength Comparisons >> Go to Compare CNTG Quick Ratio to its Competitors

On the trailing twelve months basis Due to unchanged in Current Liabilities in the Q4 2023 to $48.57 millions, cumulative Quick Ratio decreased to 0.44 below the Centogene N V average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Laboratories industry 47 other companies have achieved higher Quick Ratio than Centogene N V . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 3344 to 4643.

Explain Quick Ratio?
How much Cash & cash equivalents CNTG´s has?
What are CNTG´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Laboratories Industry # 48
Healthcare Sector # 1153
Within the Market # 4643


trailing twelve months Quick Ratio Statistics
High Average Low
0.9 0.67 0.44
(Dec 31 2022)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Medical Laboratories Industry Quick RatioDec 31 2023 MRQ Cash & cash equivalentDec 31 2023 MRQ Current Liabilities
WEED, INC.  1.01 $ 0.290  Millions$ 0.288  Millions
Ispecimen inc   0.83 $ 5.033  Millions$ 6.049  Millions
Radnet Inc   0.80 $ 388.903  Millions$ 488.055  Millions
Natera Inc   0.79 $ 236.882  Millions$ 298.962  Millions
Biodesix Inc   0.79 $ 26.284  Millions$ 33.416  Millions
Medpace Holdings Inc   0.67 $ 245.449  Millions$ 365.271  Millions
Psychemedics Corporation  0.54 $ 1.964  Millions$ 3.661  Millions
Mdxhealth Sa  0.50 $ 22.380  Millions$ 45.018  Millions
Grail Inc   0.47 $ 97.287  Millions$ 207.192  Millions
Centogene N v   0.44 $ 21.391  Millions$ 48.570  Millions
Renalytix Plc  0.40 $ 5.619  Millions$ 13.922  Millions
Quest Diagnostics Inc  0.37 $ 686.000  Millions$ 1,831.000  Millions
Inotiv Inc   0.35 $ 22.001  Millions$ 62.563  Millions
Charles River Laboratories International inc   0.33 $ 276.771  Millions$ 835.964  Millions
Aclarion Inc   0.32 $ 1.021  Millions$ 3.188  Millions
Iqvia Holdings Inc   0.32 $ 1,496.000  Millions$ 4,716.000  Millions
Koninklijke Philips Nv  0.25 $ 2,339.680  Millions$ 9,420.677  Millions
Fortrea Holdings Inc   0.22 $ 108.600  Millions$ 494.400  Millions
Nrc Health  0.18 $ 6.653  Millions$ 37.924  Millions
Labcorp Holdings Inc   0.16 $ 536.800  Millions$ 3,264.100  Millions
Icon Plc  0.12 $ 380.056  Millions$ 3,203.859  Millions
Capforce Inc   0.10 $ 1.152  Millions$ 11.422  Millions

Date modified: 2026-09-08T15:11:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.